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Abstract
Background:  Usefulness of prophylactic antibiotics following tube thoracostomy remains
controversial in the literature. In this study, we aimed to investigate the consequences of closed
tube thoracostomy for primary spontaneous pneumothorax without the use of antibiotics.
Methods:  One-hundred and nineteen patients underwent tube thoracostomy for primary
spontaneous pneumothorax. None of them received prophylactic antibiotic treatment. Eight
patients with prolonged air leak undergoing either video assisted thoracoscopic surgery or
thoracotomy were excluded.
Results: Of the remaining 111 (104 male and 7 female), 28 (25%) patients developed some
induration around the entry site of chest tube that settled without further treatment. White blood
cell count was high without any other evidence of infection in 12 (11%) patients and returned to
its normal levels before discharge home in all. There was also some degree of fever not lasting for
more than 48 hours in 8 (7%) patients. Bacterial cultures from suspected sites did not reveal any
significant growth in these patients.
Conclusion: Prophylactic antibiotic treatment seems avoidable during closed tube thoracostomy
for primary spontaneous pneumothorax. This policy was not only cost-effective but also prevented
our patients from detrimental properties of unnecessary antibiotic use, such as development of
drug resistance and undesirable side effects.
Background
Primary spontaneous pneumothorax (PSP) usually occurs
following rupture of a subpleural bleb or bulla located at
apices of the lungs without an associated underlying pul-
monary disease. It is most frequently seen in tall, smoker
and young adults with a male to female ratio of 6:1 [1,2].
Evacuation of the pleural air with simple aspiration or
closed tube thoracostomy (CTT) is the treatment of choice
in most cases. More invasive surgical procedures such as
bullectomy and/or pleurodesis with either pleurectomy or
pleural abrasion are usually recommended in cases with
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recurrent disease and occasionally at the first episode in
certain circumstances [1].
Different opinions exist regarding the use of prophylactic
antibiotics following insertion of a chest tube and only
very few and rather old papers on this topic are listed in
recent literature [3,4]. BTS (British Thoracic Society)
guidelines for the management of spontaneous pneumot-
horax either do not examine or give indications on antibi-
otics use. Attention was pointed only toward the
importance of sterile technique in CTT [1]. Antibiotics are
not obligatory for the prophylaxis of surgical infections in
the current practice. It may therefore be omitted in cases
with no additional risk factors necessitating antibiotic
prophylaxis following CTT [5]. Thus, we have adopted our
practice accordingly, and have not been using prophylac-
tic antibiotics in such cases since the beginning of the year
2001. This study aims to rationalize the use of prophylac-
tic antibiotics in this cohort of patients and compare our
three and a half years of experience with those of reported
in the medical literature.
Methods
One hundred and nineteen patients underwent CTT for
PSP between January 2001 and June 2004. Eight patients
with prolonged air leak (> 7 days) undergoing either
video-assisted thoracoscopic surgery or thoracotomy were
started on our standard prophylactic antibiotic treatment
[6] and therefore excluded from the study. Data of the
remaining 111 patients was extracted from hospital's case
notes and evaluated retrospectively.
Diagnosis of a PSP was achieved on the basis of postero-
anterior chest X-ray (CXR) together with detailed ques-
tioning of patient's past medical history. A computerized
tomography of the chest was also obtained for patients in
whom the diagnosis was unconvinced. Patients with sec-
ondary spontaneous pneumothorax and those of PSP in
association with either history of a malignancy or a sys-
temic disease (e.g. diabetes mellitus, steroid use, chemo-
therapy etc.) were excluded from the study.
CTT was performed in a sterile setting in the emergency
room using 10% povidone iodine for skin antisepsis and
2% Lidocaine for local anaesthesia. According to patient's
body size, chest tubes of either 20 or 24 Fr size were
inserted via 5th or 6th intercostal space at the mid-axillary
line of the affected site, fixed to the skin with No. 0 silk
suture and connected to an under-water seal drainage sys-
tem. Position of the drain and lung expansion was verified
with a control CXR that was obtained within one hour fol-
lowing the procedure. If the lung was not fully expanded,
a suction of 20 cm H2O was applied on the drain. Pain
relief was achieved with divided daily oral doses of 2 g. of
paracetamol and 150 mg. of diclofenac sodium as well as
20 mg. of omeprazole per orally for the stomach protec-
tion. Full blood count, biochemistry, erythrocyte sedi-
mentation rate (ESR), C-reactive protein (CRP) and urine
analysis were obtained for all patients on admission. After
the procedure all patients were evaluated according to the
National Nasocomial Infection Surveillance (NNIS) Sys-
tem definitions for surgical site infections [7]. Body tem-
perature, systemic blood pressure and pulse rates were
recorded twice daily. White blood cell (WBC) count, ESR
and CRP were repeated and samples were taken for cul-
tures in the presence of any clinical evidence that suggests
infection such as fever, infiltration in the lung paren-
chyma on CXR or turbid colour change of pleural drain-
age fluid. Chest tubes were removed 24 hours after
cessation of the air leak and ensuing complete lung expan-
sion on CXR. Air leak persisting for more than 7 days was
accepted as "prolonged air leak". Those patients were con-
sidered for elective surgery, thus were excluded from the
study. Drain stitches were removed as an outpatient on
the 7th day following discharge from the hospital for all
patients.
Results
Of the 111 patients, there were 104 male and 7 female
(M/F ratio = 15:1) with a mean age of 34.2 ± 9.7 (Range:
16 – 52) Patient's other demographic an clinical details
are also shown in Table 1. Duration of the CTT was 2 days
in 19 (17%), 3 days in 58 (53), 4 days in 29 (26%) and 5
days in 5 (4%) patients with a median of 3 days.
Table 1: Patient's Demographic Data and Clinical Findings.
n = 111
Mean Age ± SD (Min. – Max.) 34,2 ± 9,7 (16 – 52)
Gender (Male/Female) 104/7 (15:1)
Site of Pneumothorax (Left/Right) 65/46
Size of Pneumothorax (Partial/Total) 85/26
Duration of Tube Thoracostomy (Median: 3 days) 2 days: 19 (%17)
3 days: 58 (%53)
4 days: 29 (%26)
5 days: 5 (%4)Journal of Cardiothoracic Surgery 2006, 1:43 http://www.cardiothoracicsurgery.org/content/1/1/43
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Local induration of skin around the entry site of the chest
tube was observed in 28 (25%) patients and was attrib-
uted to local reaction of the foreign material and invasive
procedure. None of them showed any systemic signs of
infection, like fever, tachycardia or tachypnea. These
patients were followed more closely without any interven-
tion, and all of the local signs disappeared within two
weeks time following removal of drain stitches without an
additional treatment. In a subgroup analysis, WBC was
found to be more than 11 × 103.µL-1 without an increase
in either body temperature or serum CRP level in 12
(11%) patients and cultures from different sites did not
show any significant growth. Therefore no antibiotics
were started on these patients. On the other hand, 8 (%7)
patients developed some degree of fever, not lasting for
more than 48 hours. Their WBC and serum CRP levels
were also within normal limits and cultures from sus-
pected sites also remained sterile. None of the remaining
91 (82%) patients developed any clinical evidence of
infection, therefore, neither routine blood tests were
repeated nor were culture and susceptibility tests per-
formed for these patients.
Discussion
CTT is generally accepted as the first choice of treatment in
the management of PSP. Other alternative treatment
modalities such as oxygen inhalation with bed rest or sim-
ple aspiration using fine bore catheters [1] may be consid-
ered for patients with a small pneumothorax. Chemical
pleurodesis after CTT or pleurectomy with the use of
video-assisted thoracoscopy is recommended for recur-
rent episodes or even for the first episode in certain cir-
cumstances [8,9]. Patients who underwent CTT usually
require hospitalization and their chest tubes are removed
ensuing that air leak ceased and complete lung expansion
has been achieved. Most patients are discharged home 24
hours after drain removal following a control CXR [5].
Wounds are classified in to 4 groups in surgical practice:
clean, clean-contaminated, contaminated and dirty. As a
surgical intervention, CTT is included in the "clean-con-
taminated" group of surgical wounds and infection risk of
such a wound is 7.7% [10]. Although relevant reports are
very limited in the literature, different opinions exist
regarding the use of prophylactic antibiotics after CTT. An
incidence of up to 6% of chest tube related empyema has
been reported in trauma cases and suggested that the
administration of prophylactic antibiotics should be con-
sidered, particularly where a prolonged period of chest
tube drainage might be anticipated [11,12]. In an old con-
trolled study [3] in which clindamycin was chosen for
prophylaxis following CTT, the rates of pleural infection
were 2,6% and 16% in the clindamycin and control
groups, respectively. In contrast, prophylactic antibiotic
use caused an increased morbidity in another study [4].
Patients with PSP are usually young adults with no sys-
temic diseases and have enough resistance to bacterial
infections. Because duration of CTT is less than a week
and the procedure is also performed in a sterile environ-
ment, possibility of a bacterial infection is negligible in
most cases. Thus, administration of a prophylactic antibi-
otic after CTT was omitted in patients who sustained PSP
with no systemic disease during the study period of 3
years. We have also carefully monitored WBC counts and
serum CRP levels as well as some clinical signs suggesting
presence of an infection such as fever, tachycardia, and
turbid appearance of the draining fluid and inflammation
around the entry site of the chest tubes before making the
diagnosis of an infection. Minimal inflammation and
induration confined to the wound site have carefully been
assessed in view of NNIS descriptions and were consid-
ered as foreign body reaction rather than a superficial
infection. None of our patients developed any clinical
signs (e.g. purulent discharge from the wound site, persist-
ing fever, deterioration of the general condition, sepsis,
pneumonia, empyema etc.) suggesting an infection that
would necessitate an antibiotic treatment, and therefore
supported our initial hypothesis. Following three and a
half years of experience regarding this particular matter,
we continue to employ the same policy with no increase
in either infection or complication rates in our practice.
Unnecessary use of antibiotics has some consequences for
both the individual patient and the institution regarding
the cost-effectiveness and adverse reactions. Prophylactic
antibiotic use has also been shown to have a critical role
in the selection of antibiotic resistant bacteria to become
the dominant colonizing flora and nasocomial pathogens
for hospitalized patients [13]. Moreover, one would pre-
dict that increasing reliance on the most potent antibiotics
used for prophylaxis will -in time- be associated with fur-
ther increases in the prevalence of these antibiotic-resist-
ant strains.
Conclusion
Our study proved that the patients presenting with PSP do
not require antibiotic prophylaxis during CTT. We believe
in that such an approach not only decreases the cost of
treatment but also prevents patients from undesired side
effects of antibiotics.
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